| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |